This study, conducted in a Japanese cohort, highlights the complexity of interpreting natriuretic peptides—BNP and NT-proBNP—in patients with CKD, which may differ from Western populations due to differences in etiology, healthcare practices, and the accessibility of dialysis therapy. This evidence concerns the gene NPPB and chronic kidney disease.